|
1
|
Sasaki H, Endo K, Konishi A, et al: EGFR
mutation status in Japanese lung cancer patients: genotyping
analysis using LightCycler. Clin Cancer Res. 11:2924–2929. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nicholson RI, Gee JM and Harper ME: EGFR
and cancer prognosis. Eur J Cancer. 37(Suppl 4): S9–S15. 2001.
View Article : Google Scholar
|
|
3
|
Ohsaki Y, Tanno S, Fujita Y, et al:
Epidermal growth factor receptor expression correlates with poor
prognosis in non-small cell lung cancer patients with p53
overexpression. Oncol Rep. 7:603–607. 2000.PubMed/NCBI
|
|
4
|
Scaltriti M and Baselga J: The epidermal
growth factor receptor pathway: a model for targeted therapy. Clin
Cancer Res. 12:5268–5272. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lynch TJ, Bell DW, Sordella R, et al:
Activating mutations in the epidermal growth factor receptor
underlying responsiveness of non-small-cell lung cancer to
gefitinib. N Engl J Med. 350:2129–2139. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Paez JG, Janne PA, Lee JC, et al: EGFR
mutations in lung cancer: correlation with clinical response to
gefitinib therapy. Science. 304:1497–1500. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shigematsu H, Lin L, Takahashi T, et al:
Clinical and biological features associated with epidermal growth
factor receptor gene mutations in lung cancers. J Natl Cancer Inst.
97:339–346. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Borras E, Jurado I, Hernan I, et al:
Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations
by high resolution melting analysis and ultra-deep pyrosequencing.
BMC Cancer. 11:406–415. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yasuda H, Kobayashi S and Costa DB: EGFR
exon 20 insertion mutations in non-small-cell lung cancer:
preclinical data and clinical implications. Lancet Oncol.
13:e23–e31. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Murray S, Dahabreh IJ, Linardou H,
Manoloukos M, Bafaloukos D and Kosmidis P: Somatic mutations of the
tyrosine kinase domain of epidermal growth factor receptor and
tyrosine kinase inhibitor response to TKIs in non-small cell lung
cancer: an analytical database. J Thorac Oncol. 3:832–839. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Linardou H, Dahabreh IJ, Bafaloukos D,
Kosmidis P and Murray S: Somatic EGFR mutations and efficacy of
tyrosine kinase inhibitors in NSCLC. Nat Rev Clin Oncol. 6:352–366.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Han SW, Kim YT, Hwang PG, et al:
Predictive and prognostic impact of epidermal growth factor
receptor mutation in non-small-cell lung cancer patients treated
with gefitinib. J Clin Oncol. 23:2493–2501. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Carey KD, Garton AJ, Romero MS, et al:
Kinetic analysis of epidermal growth factor receptor somatic mutant
proteins shows increased sensitivity to the epidermal growth factor
receptor tyrosine kinase inhibitor, erlotinib. Cancer Res.
66:8163–8171. 2006. View Article : Google Scholar
|
|
14
|
Sriram KB, Tan ME, Savarimuthu SM, et al:
Screening for activating EGFR mutations in surgically resected
nonsmall cell lung cancer. Eur Respir J. 10:455–465.
2011.PubMed/NCBI
|
|
15
|
Taylor CF: Mutation scanning using
high-resolution melting. Biochem Soc Trans. 37:433–437. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stroun M, Anker P, Maurice P, Lyautey J,
Lederrey C and Beljanski M: Neoplastic characteristics of the DNA
found in the plasma of cancer patients. Oncology. 46:318–322. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sorenson GD, Pribish DM, Valone FH, Memoli
VA, Bzik DJ and Yao SL: Soluble normal and mutated DNA sequences
from single copy genes in human blood. Cancer Epidemiol Biomarkers
Prev. 3:67–71. 1994.PubMed/NCBI
|
|
18
|
Vasioukhin V, Anker P, Maurice P, Lyautey
J, Lederrey C and Stroun M: Point mutations of the N-ras gene in
the blood plasma DNA of patients with myelodysplastic syndrome or
acute myelogenous leukaemia. Br J Haematol. 86:774–779. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
NCBI/BLAST. http://blast.ncbi.nlm.nih.gov/Blast.cgi.
|
|
20
|
Horn L and Pao W: EML4-ALK: Honing in on a
new target in non-small-cell lung cancer. J Clin Oncol.
27:4232–4235. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Choi YL, Soda M, Yamashita Y, et al:
EML4-ALK mutations in lung cancer that confer resistance to ALK
inhibitors. N Engl J Med. 363:1734–1739. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pao W and Girard N: New driver mutations
in non-small-cell lung cancer. Lancet Oncol. 12:175–180. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sequist LV, Bell DW, Lynch TJ and Haber
DA: Molecular predictors of response to epidermal growth factor
receptor antagonists in non-small-cell lung cancer. J Clin Oncol.
25:587–595. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Uramoto H and Mitsudomi T: Which biomarker
predicts benefit from EGFR-TKI treatment for patients with lung
cancer? Br J Cancer. 96:857–863. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jackman DM, Yeap BY, Sequist LV, et al:
Exon 19 deletion mutations of epidermal growth treated with
gefitinib or erlotinib. Clin Cancer Res. 12:3908–3914. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Riely GJ, Pao W, Pham D, et al: Clinical
course of patients with non-small cell lung cancer and epidermal
growth factor receptor exon 19 and exon 21 mutations treated with
gefitinib or erlotinib. Clin Cancer Res. 12:839–844. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mitsudomi T, Kosaka T, Endoh H, et al:
Mutations of the epidermal growth factor receptor gene predict
prolonged survival after gefitinib treatment in patients with
non-small cell lung cancer with postoperative recurrence. J Clin
Oncol. 23:2513–2520. 2005. View Article : Google Scholar
|
|
28
|
Pao W and Ladanyi M: Epidermal growth
factor receptor mutation testing in lung cancer: searching for the
ideal method. Clin Cancer Res. 13:4954–4955. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bosquet JG, Calcei J, Wei JS, et al:
Detection of somatic mutations by high-resolution DNA melting (HRM)
analysis in multiple cancers. PLoS One. 6:e145222011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nomoto K, Tsuta K, Takano T, et al:
Detection of EGFR mutations in archived cytologic specimens of
non-small cell lung cancer using high resolution melting analysis.
Am J Clin Pathol. 126:608–615. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Camila GC and Mauricio RL: The use of
high-resolution melting analysis for genotyping Symbiodinium
strains: a sensitive and fast approach. Mol Ecol Resour.
11:394–399. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sriram KB, Tan ME, Savarimuthu SM, et al:
Screening for activating EGFR mutations in surgically resected
nonsmall cell lung cancer. Eur Respir J. 38:903–910. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Takano T, Ohe Y, Tsuta K, et al: Epidermal
growth factor receptor mutation detection using high-resolution
melting analysis predicts outcomes in patients with advanced non
small cell lung cancer treated with gefitinib. Clin Cancer Res.
18:5385–5390. 2007. View Article : Google Scholar
|
|
34
|
Bell DW, Lynch TJ, Haserlat SM, et al:
Epidermal growth factor receptor mutations and gene amplification
in non-small-cell lung cancer: molecular analysis of the
IDEAL/INTACT gefitinib trials. J Clin Oncol. 23:8081–8092. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sharma SV, Bell DW, Settleman J and Haber
DA: Epidermal growth factor receptor mutations in lung cancer. Nat
Rev Cancer. 7:169–181. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Smith GD, Chadwick BE, Willmore-Payne C
and Bentz JS: Detection of epidermal growth factor receptor gene
mutations in cytology specimens from patients with non-small cell
lung cancer utilising high-resolution melting amplicon analysis. J
Clin Pathol. 61:487–493. 2008. View Article : Google Scholar : PubMed/NCBI
|
